You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨歌禮制藥(01672.HK)高開3.56% 二期NASH臨牀數據表現上佳
格隆匯 06-18 09:31
格隆匯6月18日丨歌禮制藥(01672.HK)高開3.56%,報3.2港元,總市值35.4億港元。歌禮制藥(01672.HK)公佈,公司的業務夥伴之一Sagimet Biosciences Inc.今日公佈有關口服(每日一次)非酒精性脂肪肝炎(NASH)候選藥物TVB-2640(公司代號:ASC40)的二期(FASCINATE-1)臨牀試驗數據。初步數據顯示TVB-2640顯著降低了肝臟脂肪含量(此試驗的主要療效終點),50mg組別中的應答率為61%。受試者還表現出肝功能和纖維化指標的改善。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account